The management of antiretroviral treatments in Europe
Universal health coverage and HIV in resource-constrained countries
Moxifloxacin for Buruli ulcer/HIV coinfected patients
A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia
Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection
High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy
Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy
Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B
Zidovudine impairs immunological recovery on first-line antiretroviral therapy
Progression to and spontaneous regression of high-grade anal squamous intraepithelial lesions in HIV-infected and uninfected men
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers
Microbicides from a regulatory perspective
Lost or just not following up
Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective
Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women
Dramatic increase in HIV prevalence after scale-up of antiretroviral treatment
Cell-to-cell vs. cell-free HIV-1 transmission from macrophages to CD4+ T lymphocytes
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France
Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe
Clinical, radiological and laboratory features of human metapneumovirus lower respiratory tract infection in HIV-positive patients
Response to Lancaster et al. generalizability and scalability of HIV ‘treatment as prevention’
Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition